Evidence map›Paper›PMID 35405131›Full record

ArticleEnvironmental research2022

Phthalate biomarkers and associations with respiratory symptoms and healthcare utilization among low-income urban children with asthma.

Magdalena Fandiño-Del-Rio, Elizabeth C Matsui, Roger D Peng, John D Meeker, Lesliam Quirós-Alcalá

Abstract read
In one paragraph

Article in Environmental research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Magdalena Fandiño-Del-RioJohns Hopkins University, Bloomberg School of Public Health, Department of Environmental Health and Engineering, Baltimore, MD, USA. Electronic address: mfandin2@jhu.edu.
Elizabeth C MatsuiDell Medical School, University of Texas, Austin, TX, USA. Electronic address: elizabeth.matsui@austin.utexas.edu.
Roger D PengJohns Hopkins University, Bloomberg School of Public Health, Department of Biostatistics, Baltimore, MD, USA. Electronic address: rdpeng@jhu.edu.
John D MeekerDepartment of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI, USA. Electronic address: meekerj@umich.edu.
Lesliam Quirós-AlcaláJohns Hopkins University, Bloomberg School of Public Health, Department of Environmental Health and Engineering, Baltimore, MD, USA. Electronic address: lquiros@jhu.edu.

Funding

Untargeted Analysis ResourceU2CES026553 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MEEKER, JOHN D. · 2015 to 2015
$9.5M
The effect of a housing mobility program on environmental exposures and asthma morbidity among low-income minority childrenR01ES026170 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI KEET, CORINNE, MATSUI, ELIZABETH C. · 2016 to 2025
$6.8M
Pilot Project ProgramP30ES032756 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI Thomas Hartung · 2022 to 2026
$6.0M
Environmental Control as Add-on Therapy in Urban Children with AsthmaR01ES023447 · NIEHS · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2014 to 2018
$3.4M
The MELENA Study: Measurement of Exposures, Lung hEalth, and functioN in hAirdressersR01HL171490 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Lesliam Quiros-Alcala · 2024 to 2026
$2.1M
Mentoring in Patient-Oriented Research on Asthma and the Indoor EnvironmentK24AI114769 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI MATSUI, ELIZABETH C. · 2015 to 2023
$1.6M
Antimicrobial Agents and Asthma Morbidity among African American Children withAsthmaK01HL138124 · NHLBI · UNIV OF MARYLAND, COLLEGE PARK · PI QUIROS-ALCALA, LESLIAM · 2017 to 2021
$666k
Mouse Allergen Exposure &Mouse Allergic SensitizationK23AI060955 · NIAID · JOHNS HOPKINS UNIVERSITY · PI MATSUI, ELIZABETH C. · 2005 to 2007
$404k
NHLBI NIH HHS K01 HL138124NHLBI NIH HHS R01 HL171490NIAID NIH HHS K23 AI060955NIAID NIH HHS K24 AI114769NIEHS NIH HHS P30 ES032756NIEHS NIH HHS R01 ES023447NIEHS NIH HHS R01 ES026170NIEHS NIH HHS U2C ES026553NIOSH CDC HHS T42 OH008428
6 · The paper itself

Abstract

backgroundPhthalates are synthetic chemicals present in building materials, personal care products and other consumer goods. Limited studies link phthalates to pediatric asthma incidence; however, their effects on respiratory-related outcomes among those with pre-existing asthma remains unclear.

objectiveWe examined associations between phthalates and asthma symptoms, healthcare use, lung function, and lung inflammation among children with asthma.

methodsWe collected repeated measures of urinary biomarkers for select phthalates and phthalate replacements (MBzP, MCINP, MCIOP, MCPP, MECPTP, MEHHTP, molar sum of DEHP biomarkers [MECPP, MEHHP, MEHP, MEOHP], MEP, MiBP, MnBP) and asthma symptoms, healthcare utilization, lung function, and inflammation among 148 predominantly low-income Black children (5-17 years) with persistent asthma every 3 months for one year. We used generalized estimating equations to assess associations between biomarker concentrations and asthma-related measures adjusting for age, sex, race/ethnicity, caregiver's education level, presence of smokers in the home, and season. We also considered co-exposures to other contaminants previously associated with asthma morbidity.

resultsWe observed consistent positive associations with individual DEHP biomarkers, the molar sum of DEHP, and BBzP with increased odds of asthma symptoms and with healthcare utilization (adjusted Odds Ratio for general asthma symptoms: ΣDEHP:1.49,95% Confidence Interval, CI:1.08-2.07; BBzP:1.34, CI:1.04-1.73). We observed similar associations between the DEHP phthalate replacement biomarker MEHHTP and most asthma symptoms evaluated; and with select low molecular weight phthalates (DiBP, DBP) and healthcare utilization. Results were similar when controlling for other environmental exposures (e.g., PM

conclusionIn the present study, we found evidence to suggest that exposure to select phthalates may be associated with asthma symptoms and healthcare utilization. These findings warrant confirmation given the high asthma burden and widespread and disparate phthalate exposures reported among select populations of color.

Indexed as

AsthmaDiethylhexyl PhthalateEnvironmental PollutantsPhthalic AcidsBiomarkersChildDelivery of Health CareEnvironmental ExposureHumansInflammationPatient Acceptance of Health CareUrban PopulationBiomarkersDiethylhexyl PhthalateEnvironmental Pollutantsphthalic acidPhthalic AcidsAsthma symptoms and healthcare utilizationChildhood asthmaUrinary phthalate biomarkers

Identifiers

PMID35405131
PMCPMC13112366

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.